This pancreatic cancer treatment is on track for ‘one of the best drug launches of all time’
MarketWatch· Jaimy Lee· Nov 5, 2026 · 4:12 PM
Revolution Medicines’ brand-new treatment brought in far higher sales than expected in its first few weeks on the market.
This is a summary. Read the complete story at MarketWatch below.
Read full article at MarketWatchRelated Stories
marketsabout 5 hours ago
Nvidia, AMD and other chip stocks rebound. Is the ‘violent’ AI selloff over?
Analysts warn of further volatility ahead, though there are two new factors that work in the AI trade’s favor.
MarketWatch
marketsabout 5 hours ago
These three stars need to align before investors rush back into stocks, Bank of America strategist says
Despite the steep drop in equity markets this week, investors should wait for several developments in other asset markets before rushing back into stocks, Michael Hartnett said.
MarketWatch
marketsabout 6 hours ago
U.S. economy added 165,000 jobs in October, way more than expected; unemployment rate slips to 4.1%
Nonfarm payrolls were expected to increase by 59,000 in October as the unemployment rate was expected to hold steady at 4.2%.
CNBC Markets